CYP2D6 and breast cancer: CYP2D6 *10 lost its significance when all the other SNPs were adjusted together in the multiple stepwise selection COX model, which may explain why the associations of CYP2D6 and the survival of tamoxifen-treated breast cancer patients conflict in different reports.